findmyKOL
Clinical trialNCT01967888CompletedPhase 2/PHASE3Interventional

Efficacy and Safety of Reparixin in Pancreatic Islet Auto-transplantation

SponsorDompé Farmaceutici S.p.AEnrollment104Pancreatectomy for Chronic Pancreatitis
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

  • Melena Bellin, MD

    Schulze Diabetes Institute; University of Minnesota Amplatz Children's Hospital

    Principal Investigator

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

9 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Canada
  • University of Alberta, Clinical Islet Transplant Program

    Edmonton, Alberta, Canada

United States
  • University of California. Department of Surgery, Division of Transplantation

    San Francisco, California, United States

  • the University of Chicago Medical Center

    Chicago, Illinois, United States

  • Schulze Diabetes Institute University of Minnesota Medical School

    Minneapolis, Minnesota, United States

  • Dartmouth-Hitchcock Medical Center

    Lebanon, New Hampshire, United States

  • the University of Cincinnati Medical Center

    Cincinnati, Ohio, United States

  • Thomas E. Starzl Transplantation Institute University of Pittsburgh Medical Center

    Pittsburgh, Pennsylvania, United States

  • Medical University of South Carolina

    Charleston, South Carolina, United States

  • Baylor University Medical Center

    Dallas, Texas, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
28 Feb 2014
Primary completion
31 Jan 2018
Completion
31 Jan 2018
Last update posted
2 Nov 2023
Registered enrollment
104
Registry id
NCT01967888

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.